Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 14
More JCP Articles
Original Research
Severity of Antipsychotic-Induced Cervical Dystonia by Algorithm-Based Rating System
April 15, 2024
Rater consensus data were compared with deviation angle data using AI-based deviation angle measurement technology. With the range of tilt angles found in the study, the authors propose a…
Original Research
Psychological Pain as a Risk Factor for Suicidal Ideation
April 8, 2024
In inpatients with depression, psychological pain is a risk factor for suicidal ideation. Those with borderline personality disorder may experience more prominent and temporally unstable psychological pain, likely underlying…
Case Report
Serotonin Syndrome and Dextromethorphan Toxicity Caused by Fluoxetine and Bupropion-Dextromethorphan Interaction
April 3, 2024
Addition of bupropion-dextromethorphan (BUP/DXM) to existing fluoxetine treatment resulted in serotonin syndrome within 3 days, with symptoms prompting presentation to the ED 5 days after discontinuation of BUP/DXM.
Letter to the Editor
Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?
March 20, 2024
As choice of administration route is crucial during psychiatric emergencies, the authors stress the need for RCTs comparing onset of efficacy for agitation across different administration routes of the…
Original Research
Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior in Preschool-Aged Children
March 13, 2024
Outcomes of children exposed in utero to second-generation antipsychotics (SGAs) were compared to those of children unexposed to SGAs in a cohort of mothers with a history of psychiatric…
Clinical and Practical Psychopharmacology
Diabetic medications and major congenital malformations
March 11, 2024
Diabetes is prevalent and poses risks to both mother and child during pregnancy. Evidence shows that diabetes is best treated during pregnancy, with insulin a first-line treatment and metformin…
Original Research
Safety and Tolerability of Initiating With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months
February 28, 2024
In this post hoc analysis, treatment of acutely exacerbated schizophrenia with aripiprazole lauroxil or paliperidone palmitate was well tolerated, consistent with the safety profiles of these medications.
